Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2132 | LifeSignals Biosensor 1AX* Wiki | 1.00 |
| drug3071 | Pregnant women under investigation for Coronavirus or diagnosed with COVID-19 Wiki | 1.00 |
| drug3728 | Standard of Care Wiki | 0.16 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) is a prospective cohort study of pregnant and recently pregnant women who are: either patients under investigation for COVID-19 or a confirmed case of COVID-19. Data from PRIORITY will be used to evaluate the impact of COVID-19 on the clinical course and pregnancy outcomes of pregnant women and women within 6 weeks of pregnancy.
Description: presenting symptoms and testing
Measure: Clinical presentation Time: Baseline to 12 monthsDescription: Clinical outcomes with resolution of illness
Measure: Disease prognosis outcomes Time: Baseline to 12 monthsDescription: Pregnancy outcomes among women infected with COVID-19
Measure: Pregnancy outcomes Time: Baseline to 12 monthsDescription: Obstetric outcomes among women infected with COVID-19
Measure: Obstetric outcomes Time: Baseline to 12 monthsDescription: Neonatal outcomes among infants born to women with COVID-19
Measure: Neonatal outcomes Time: Baseline to 12 monthsDescription: Transmission of COVID-19 from mother to infant
Measure: Modes of transmission of COVID-19 Time: Baseline to 12 monthsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports